GlassScriptPhysician profile
Amy Palmer
NPI 1891384715
$2,986.08
in general payments reported to CMS, 2019-2025
16 companies · $1,430 in 2025
The $1,430 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $738 · 2024: $819 · 2025: $1,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,149 · Travel and Lodging: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,149.36 |
| Travel and Lodging | $836.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,171.16 | 2025 | Minimed 780g |
| Insulet Corporation | $348.68 | 2023-2025 | Omnipod, Omnipod |
| Beta Bionics, INC. | $202.72 | 2024 | Ilet Bionic Pancreas |
| Amgen INC. | $190.20 | 2023-2024 | Prolia, Evenity, Repatha |
| Lilly USA, LLC | $163.60 | 2023-2024 | Mounjaro, Jardiance |
| Neurocrine Biosciences, INC. | $139.29 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2024 | Jardiance |
| Horizon Therapeutics Plc | $125.00 | 2023 | Tepezza |
| Radius Health, INC. | $116.62 | 2024 | Tymlos |
| Inspire Medical Systems, INC. | $109.25 | 2023 | Inspire |
| Novo Nordisk INC | $103.00 | 2023-2024 | Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $58.39 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $58.32 | 2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $40.17 | 2023 | Recorlev |
| Amryt Pharma Holdings LTD | $18.33 | 2023 | Mycapssa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.